ProShare Advisors
SGYP

ProShare Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

ProShare Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-131,537
Closed -$224K – 1784
2018
Q3 		$224K Sell
131,537
-4,896
-4% -$8.76K ﹤0.01% 1530
2018
Q2 		$237K Sell
136,433
-9,398
-6% -$16.2K ﹤0.01% 1519
2018
Q1 		$267K Sell
145,831
-23,971
-14% -$50.6K ﹤0.01% 1386
2017
Q4 		$379K Buy
169,802
+27,511
+19% +$68.4K ﹤0.01% 1265
2017
Q3 		$413K Buy
142,291
+6,788
+5% +$23.2K ﹤0.01% 1037
2017
Q2 		$603K Buy
135,503
+5,405
+4% +$22.3K 0.01% 889
2017
Q1 		$606K Sell
130,098
-17,928
-12% -$104K 0.01% 944
2016
Q4 		$901K Buy
148,026
+16,916
+13% +$88.4K 0.01% 823
2016
Q3 		$722K Sell
131,110
-24,903
-16% -$117K 0.01% 795
2016
Q2 		$593K Buy
156,013
+59,611
+62% +$202K 0.01% 895
2016
Q1 		$266K Sell
96,402
-9,576
-9% -$34.7K ﹤0.01% 1264
2015
Q4 		$601K Buy
105,978
+10,655
+11% +$65K 0.01% 956
2015
Q3 		$505K Buy
95,323
+2,759
+3% +$21.4K 0.01% 937
2015
Q2 		$768K Sell
92,564
-3,373
-4% -$16.3K 0.01% 896
2015
Q1 		$443K Buy
95,937
+11,834
+14% +$38.5K 0.01% 1243
2014
Q4 		$257K Sell
84,103
-1,958
-2% -$5.79K ﹤0.01% 1621
2014
Q3 		$240K Sell
86,061
-16,487
-16% -$59.8K ﹤0.01% 1856
2014
Q2 		$417K Sell
102,548
-48,062
-32% -$204K 0.01% 1697
2014
Q1 		$800K Buy
150,610
+104,399
+226% +$585K 0.01% 1483
2013
Q4 		$257K Sell
46,211
-37,506
-45% -$162K ﹤0.01% 1206
2013
Q3 		$377K Buy
83,717
+31,959
+62% +$143K 0.01% 1711
2013
Q2 		$221K Buy
+51,758
New +$260K ﹤0.01% 1960

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ProShare Advisors's SGYP Position: Q4 2018 in Review

ProShare Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 131,537 shares — an estimated $224K sold.

ProShare Advisors first reported a position in SGYP in Q2 2013 and held it in 22 quarters. The position peaked at $901K in Q4 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • ProShare Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • ProShare Advisors sold 131,537 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $224K.
  • ProShare Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 22 quarters.
  • ProShare Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $901K in Q4 2016.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.